Email Access Update

Following ASTA’s transition away from its former management company on August 1, we are currently unable to access our @astaspice.org email accounts. We are working with our legal counsel and IT provider to resolve the issue as quickly as possible.

In the meantime, please contact ASTA Acting Executive Director and Chief Operating Officer Robb MacKie at [email protected] or 202-253-6216. We appreciate your patience.

ASTA Comments on FDA's Allergen Draft Guidance

ASTA submitted comments to the Food and Drug Administration(FDA) in August 2022 in response and support of the FDA's Draft Guidance for FDA Staff and Stakeholders: Evaluating the Public Health Importance of Food Allergens Other Than the Major Food Allergens Listed in the Federal Food, Drug, and Cosmetic Ac. ASTA comments note that this Draft Guidance provides a science-based framework for protecting public health with respect to allergen issues.

Published

08/17/2022 at 5:15 am

Views & Downloads

3